Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vsee Health (VSEE) Shares Outstanding (Diluted Average) (2023 - 2025)

Historic Shares Outstanding (Diluted Average) for Vsee Health (VSEE) over the last 3 years, with Q3 2025 value amounting to $16.5 million.

  • Vsee Health's Shares Outstanding (Diluted Average) rose 976.16% to $16.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.5 million, marking a year-over-year increase of 976.16%. This contributed to the annual value of $10.2 million for FY2024, which is 214.62% up from last year.
  • According to the latest figures from Q3 2025, Vsee Health's Shares Outstanding (Diluted Average) is $16.5 million, which was up 976.16% from $16.4 million recorded in Q2 2025.
  • In the past 5 years, Vsee Health's Shares Outstanding (Diluted Average) registered a high of $16.5 million during Q3 2025, and its lowest value of $4.2 million during Q1 2023.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $10.0 million (2023), whereas its average is $10.3 million.
  • In the last 5 years, Vsee Health's Shares Outstanding (Diluted Average) surged by 214.62% in 2024 and then skyrocketed by 25158.89% in 2025.
  • Quarter analysis of 3 years shows Vsee Health's Shares Outstanding (Diluted Average) stood at $10.0 million in 2023, then rose by 2.15% to $10.2 million in 2024, then skyrocketed by 62.04% to $16.5 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $16.5 million in Q3 2025, compared to $16.4 million in Q2 2025 and $16.3 million in Q1 2025.